Skip to main content
Signal8

United Health Products, Inc. (UEEC) Form 10-Q — Nov 17, 2026

$UEECForm 10-QFiled Nov 17, 2026, 3:46 PM ET0001477932-26-007116Original filing

United Health Products reported zero revenue for the three and nine months ended September 30, 2026, with a Q3 net loss of $185,268 and a nine-month net loss of $785,250. The company disclosed substantial doubt about its ability to continue as a going concern, holding only $5,588 in cash against negative working capital of $4,244,045. Substantially all of the company's convertible notes, including $500,000 held by related parties, mature on December 31, 2026, and management states it does not have the funds to repay them.

Key figures

Eps
0
Total Debt
4766211
Cash Position
5588
Shares Outstanding
266136416
Revenue
0
Rsu shares outstanding
40315000
Negative working capital
4244045
Error revision adjustment
108521
Notes maturing dec 31 2026
substantially all convertible notes
Shares available for issuance
36314412
Unrecognized rsu compensation
18834405
Shares issuable on notes and warrants
77757961
Convertible notes related party principal
500000

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    United Health Products, Inc. (UEEC) Form 10-Q — Nov 17, 2026: AI Analysis | Signal8